Focus on: Neuroscience and treatment: The potential of neuroscience to inform treatment

Alcohol Research and Health

Volumn 33, Issue 1-2, 2010, Pages 144-151

  Koob, George F ^a,b,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Departments of Psychology and Psychiatry   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Alcohol and other drug dependence; Alcoholism; Brain; Brain chemistry; Brain circuit; Medications; Neurotransmitters; Pharmacotherapy; Treatment

Indexed keywords

DRUGS USED IN THE TREATMENT OF ADDICTION; NARCOTIC ANTAGONIST;

ALCOHOLISM; ANIMAL; BRAIN; DRUG EFFECTS; EPIDEMIOLOGY; HUMAN; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; PATHOLOGY; PSYCHOLOGY; TREATMENT OUTCOME; TRENDS; UNITED STATES;

ALCOHOL DETERRENTS; ALCOHOLISM; ANIMALS; BIOMEDICAL RESEARCH; BRAIN; HUMANS; NARCOTIC ANTAGONISTS; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (U.S.); TREATMENT OUTCOME; UNITED STATES;

EID: 77956582672     PISSN: 15357414     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. ADDOLORATO, G.; CAPUTO, F.; CAPRISTO, E.; ET AL. Baclofen efficacy in reducing alcohol craving and intake: A preliminary doubleblind randomized controlled study. Alcohol and Alcoholism 37:504-508, 2002a. PMID: 12217947
2. ADDOLORATO, G.; CAPUTO, F.; CAPRISTO, E.; ET AL. Rapid suppression of alcohol withdrawal syndrome by baclofen. American Journal of Medicine 112:226-229, 2002b.PMID: 11893350
3. BONO, G.; BALDUCCI, C.; RICHELMI, P.; ET AL. Dopamine partial receptor agonists reduce ethanol intake in the rat. European Journal of Pharmacology 296:233-238, 1996. PMID: 8904074
4. CICCOCIOPPO, R.; ANGELETTI, S.; PANOCKA, I.; AND MASSI, M. Nociceptin/orphanin FQand drugs of abuse. Peptides 21:1071-1080, 2000. PMID: 10998542
5. COLOMBO, G.; VACCA, G.; SERRA, S.; ET AL. Baclofen suppressesmotivation to consume alcohol in rats. Psychopharmacology 167:221-224, 2003.PMID: 12669176
6. DEWITTE, P.; LITTLETON, J.; PAROT, P.; AND KOOB, G. Neuroprotective and abstinencepromoting effects of acamprosate: Elucidating the mechanism of action. CNS Drugs 19:517-537, 2005. PMID: 15963001
7. FAROOK, J.M.; LEWIS, B.; LITTLETON, J.M.; AND BARRON, S. Topiramate attenuates the stressinduced increase in alcohol consumption and preference in male C57BL/6J mice. Physiology & Behavior 96:189-193, 2009.PMID: 18786555
8. FAROOK, J.M.; MORRELL, D.J.; LEWIS, B.; ET AL. Topiramate (Topamax) reduces conditioned abstinence behaviours and handlinginduced convulsions (HIC) after chronic administration of alcohol in SwissWebster mice. Alcohol and Alcoholism 42:296-300, 2007. PMID: 17548369
9. FRYE, G.D.; MCCOWN, T.J.; AND BREESE, G.R. Differential sensitivity of ethanol withdrawal signs in the rat to gammaaminobutyric acid (GABA) mimetics: Blockade of audiogenic seizures but not forelimb tremors. Journal of Pharmacology and Experimental Therapeutics 226:720-725, 1983. PMID: 6310080
10. FUNK, C.K.; O'DELL, L.E.; CRAWFORD, E.F.; AND KOOB, G.F. Corticotropin releasing factor within the central nucleus of the amygdala mediates enhanced ethanol selfadministration in withdrawn, ethanoldependent rats. Journal of Neuroscience 26:11324-11332, 2006. PMID: 17079660
11. FUNK, C.K.; ZORRILLA, E.P.; LEE, M.J.; ET AL. Corticotropinreleasing factor 1 antagonists selectively reduce ethanol selfadministration in ethanoldependent rats. Biological Psychiatry 61:78-86, 2007. PMID: 16876134
12. GABRIEL, K.I., AND CUNNINGHAM, C.L. Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice. Alcoholism: Clinical and Experimental Research 29:75-80, 2005. PMID: 15654294
13. GEHLERT, D.R.; CIPPITELLI, A.; THORSELL, A.; ET AL. 3(4Chloro2morpholin4ylthiazol5yl)8(1ethylpropyl)2,6dimethylimidazo[1,2b] pyridazine: A novel brainpenetrant, orally available corticotropinreleasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. Journal of Neuroscience 27:2718-2726, 2007. PMID: 17344409
14. GEYER, M.A., AND MARKOU, A. Animal models of psychiatric disorders. In: Bloom, F.E., and Kupfer, D.J., Eds. Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, 1995, pp. 787-798.
15. GEORGE, D.T.; GILMAN, J.; HERSH, J.; ET AL. Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science 319:1536-1539, 2008. PMID: 18276852
16. GREMEL, C.M.; GABRIEL, K.I.; AND CUNNINGHAM, C.L. Topiramate does not affect the acquisition or expression of ethanol conditioned place preference in DBA/2J or C57BL/6J mice. Alcoholism: Clinical and Experimental Research 30:783-790, 2006. PMID: 16634846
17. HEILIG, M.; KOOB, G.F.; EKMAN, R.; AND BRITTON, K.T. Corticotropinreleasing factor and neuropeptide Y: Role in emotional integration. Trends in Neurosciences 17:80-85, 1994. PMMID: 7512773
18. HOFFMAN, P.L.; RABE, C.S.; MOSES, F.; AND TABAKOFF, B. Nmethyldaspartate receptors and ethanol: Inhibition of calcium flux and cyclic GMP production. Journal of Neurochemistry 52:1937-1940, 1989. PMID: 2542453
19. HYYTIA, P., AND KOOB, G.F. GABAA receptor antagonism in the extended amygdala decreases ethanol selfadministration in rats. European Journal of Pharmacology 283:151-159, 1995. PMID: 7498304
20. JOHNSON, B.A.; ROSENTHAL, N.; CAPECE, J.A.; ET AL. Topiramate for treating alcohol dependence: A randomized controlled trial. JAMA: Journal of the American Medical Association 298:1641-1651, 2007. PMID: 17925516
21. KALIVAS, P.W., AND MCFARLAND, K. Brain circuitry and the reinstatement of cocaineseeking behavior. Psychopharmacology 168:44-56, 2003. PMID: 12652346
22. KNAPP, D.J.; OVERSTREET, D.H.; MOY, S.S.; AND BREESE, G.R. SB242084, flumazenil, and CRA1000 block ethanol withdrawalinduced anxiety in rats. Alcohol 32:101-111, 2004. PMID: 15163561
23. KOOB, G.F. A role for brain stress systems in addiction. Neuron 59:11-34, 2008. PMID: 18614026
24. KOOB, G.F., AND LE MOAL, M. Drug abuse: Hedonic homeostatic dysregulation. Science 278:52-58, 1997. PMID: 9311926
25. KOOB, G.F., AND LE MOAL, M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nature Neuroscience 8:1442-1444, 2005. PMID: 16251985
26. KOOB, G.F., AND LE MOAL, M. Neurobiology of Addiction. London: Elsevier, 2006.
27. KOOB, G.F., AND LE MOAL, M. Addiction and the brain antireward system. Annual Review of Psychology 59:29-53, 2008. PMID: 18154498
28. KOOB, G.F.; LLOYD, G.K.; AND MASON, B.J. Development of pharmacotherapies for drug addiction: A Rosetta Stone approach. Nature Reviews. Drug Discovery 8:500-515, 2009. PMID: 19483710
29. MASON, B.J.; LIGHT, J.M.; WILLIAMS, L.D.; AND DROBES, D.J. Proofofconcept human laboratory study for protracted abstinence in alcohol dependence: Effects of gabapentin. Addiction Biology 14:73-83, 2009. PMID: 18855801
30. MELIS, M.; SPIGA, S.; AND DIANA, M. The dopamine hypothesis of drug addiction: Hypodopaminergic state. International Review of Neurobiology 63:101-154, 2005. PMID: 15797467
31. MERLOPICH, E.; LORANG, M.; YEGANEH, M.; ET AL. Increase of extracellular corticotropinreleasing factorlike immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. Journal of Neuroscience 15:5439-5447, 1995. PMID: 7643193
32. NESTLER, E.J. Is there a common molecular pathway for addiction? Nature Neuroscience 8:1445-1449, 2005. PMID: 16251986
33. O'MALLEY, S.S.; JAFFE, A.J.; CHANG, G.; ET AL. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry 49:881-887, 1992. PMID: 1444726
34. OLIVE, M.F.; KOENIG, H.N.; NANNINI, M.A.; AND HODGE, C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacology, Biochemistry, and Behavior 72:213-220, 2002. PMID: 11900791
35. OLMSTED, C.L., AND KOCKLER, D.R. Topiramate for alcohol dependence. Annals of Pharmacotherapy 42:1475-1480, 2008. PMID: 18698008
36. ORSINI, C.; KOOB, G.F.; AND PULVIRENTI, L. Dopamine partial agonist reverses amphetamine withdrawal in rats. Neuropsychopharmacology 25:789-792, 2001. PMID: 11682262
37. OVERSTREET, D.H.; KNAPP, D.J.; AND BREESE, G.R. Modulation of multiple ethanol withdrawalinduced anxietylike behavior by CRF and CRF1 receptors. Pharmacology, Biochemistry, and Behavior 77:405-413, 2004. PMID: 14751471
38. PFEIFFER, A.; BRANTL, V.; HERZ, A.; AND EMRICH, H.M. Psychotomimesis mediated by kappa opiate receptors. Science 233:774-776, 1986. PMID: 3016896
39. PULVIRENTI, L., AND KOOB, G.F. Being partial to psychostimulant addiction therapy. Trends in Pharmacological Sciences 23:151-153, 2002. PMID: 11931978
40. RASSNICK, S.; D'AMICO, E.; RILEY, E.; AND KOOB, G.F. GABA antagonist and benzodiazepine partial inverse agonist reduce motivated responding for ethanol. Alcoholism: Clinical and Experimental Research 17:124-130, 1993. PMID: 8383923
41. ROBERTO, M.; GILPIN, N.W.; O'DELL, L.E.; ET AL. Cellular and behavioral interactions of gabapentin with alcohol dependence. Journal of Neuroscience 28:5762-5771, 2008. PMID: 18509038
42. SCHROEDER, J.P.; SPANOS, M.; STEVENSON, J.R.; ET AL. Cueinduced reinstatement of alcoholseeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: Blockade by the mGluR5 antagonist MPEP. Neuropharmacology 55:546-554, 2008. PMID: 18619984
43. SILLS, G.J. The mechanisms of action of gabapentin and pregabalin. Current Opinions in Pharmacology 6:108-113, 2006. PMID: 16376147
44. SPANAGEL, R., AND KIEFER, F. Drugs for relapse prevention of alcoholism: Ten years of progress. Trends in Pharmacological Sciences 29:109-115, 2008. PMID: 18262663
45. TAYLOR, C.P.; GEE, N.S.; SU, T.Z.; ET AL. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Research 29:233-249, 1998. PMID: 9551785
46. VALDEZ, G.R.; ROBERTS, A.J.; CHAN, K.; et-alET AL/et-al. Increased ethanol selfadministration and anxietylike behavior during acute withdrawal and protracted abstinence: Regulation by corticotropinreleasing factor. Alcoholism: Clinical and Experimental Research 26:1494-1501, 2002. PMID: 12394282
47. VANDERSCHUREN, L.J., AND EVERITT, B.J. Behavioral and neural mechanisms of compulsive drug seeking. European Journal of Pharmacology 526:77-88, 2005. PMID: 16310768
48. VOLPICELLI, J.R.; ALTERMAN, A.I.; HAYASHIDA, M.; AND O'BRIEN, C.P. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49:876-880, 1992. PMID: 1345133
49. WALKER, B.M., AND KOOB, G.F. Pharmacological evidence for a motivational role of opioid systems in ethanol dependence. Neuropsychopharmacology 33:643-652, 2008. PMID: 17473837
50. WALKER, B.M.; RASMUSSEN, D.D.; RASKIND, M.A.; AND KOOB, G.F. α1Noradrenergic receptor antagonism blocks dependenceinduced increases in responding for ethanol. Alcohol 42:91-97, 2008. PMID: 18358987
51. WEISS, F., AND KOOB, G.F. Drug addiction: Functional neurotoxicity of the brain reward systems. Neurotoxicity Research 3:145-156, 2001. PMID: 15111266
52. WEISS, F.; PARSONS, L.H.; SCHULTEIS, G.; ET AL. Ethanol selfadministration restores withdrawalassociated deficiencies in accumbal dopamine and 5hydroxytryptamine release in dependent rats. Journal of Neuroscience 16:3474-3485, 1996. PMID: 8627380